A phase II study to optimize dasatinib dosing in metastatic breast cancer patients using real-time pharmacodynamic tissue and urinary biomarkers
Publication
, Conference
Herold, C; Marcom, PK; Hopkins, J; McKeen, EA; Welch, RA; Chadaram, V; Spohn, J; Ung, C; Bacus, S; Peterson, BL; Blackwell, KL
Published in: CANCER RESEARCH
January 15, 2009
Duke Scholars
Published In
CANCER RESEARCH
ISSN
0008-5472
Publication Date
January 15, 2009
Volume
69
Issue
2
Start / End Page
238S / 239S
Location
San Antonio, TX
Publisher
AMER ASSOC CANCER RESEARCH
Conference Name
31st Annual San Antonio Breast Cancer Symposium
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Herold, C., Marcom, P. K., Hopkins, J., McKeen, E. A., Welch, R. A., Chadaram, V., … Blackwell, K. L. (2009). A phase II study to optimize dasatinib dosing in metastatic breast cancer patients using real-time pharmacodynamic tissue and urinary biomarkers. In CANCER RESEARCH (Vol. 69, pp. 238S-239S). San Antonio, TX: AMER ASSOC CANCER RESEARCH.
Herold, C., P. K. Marcom, J. Hopkins, E. A. McKeen, R. A. Welch, V. Chadaram, J. Spohn, et al. “A phase II study to optimize dasatinib dosing in metastatic breast cancer patients using real-time pharmacodynamic tissue and urinary biomarkers.” In CANCER RESEARCH, 69:238S-239S. AMER ASSOC CANCER RESEARCH, 2009.
Herold C, Marcom PK, Hopkins J, McKeen EA, Welch RA, Chadaram V, et al. A phase II study to optimize dasatinib dosing in metastatic breast cancer patients using real-time pharmacodynamic tissue and urinary biomarkers. In: CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2009. p. 238S-239S.
Herold, C., et al. “A phase II study to optimize dasatinib dosing in metastatic breast cancer patients using real-time pharmacodynamic tissue and urinary biomarkers.” CANCER RESEARCH, vol. 69, no. 2, AMER ASSOC CANCER RESEARCH, 2009, pp. 238S-239S.
Herold C, Marcom PK, Hopkins J, McKeen EA, Welch RA, Chadaram V, Spohn J, Ung C, Bacus S, Peterson BL, Blackwell KL. A phase II study to optimize dasatinib dosing in metastatic breast cancer patients using real-time pharmacodynamic tissue and urinary biomarkers. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2009. p. 238S-239S.
Published In
CANCER RESEARCH
ISSN
0008-5472
Publication Date
January 15, 2009
Volume
69
Issue
2
Start / End Page
238S / 239S
Location
San Antonio, TX
Publisher
AMER ASSOC CANCER RESEARCH
Conference Name
31st Annual San Antonio Breast Cancer Symposium
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis